Pharmacokinetic Evaluation of Empagliflozin
Pharmacokinetic Evaluation of Empagliflozin in Healthy Egyptian Volunteers Using LC-MS/MS: Compared With Other Ethnic Populations
Sponsor: British University In Egypt
A PHASE1 clinical study on Diabetes Mellitus, this trial is completed. The trial is conducted by British University In Egypt and has accumulated 5 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
-
May 2017 — Jun 2018 [monthly]
Completed PHASE1
First recorded
Feb 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- British University In Egypt
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.